Can people over the age of 26 receive the 9-valent HPV vaccine?

The age limit for the 9-valent cervical cancer vaccine was previously set between 16 and 26 years old, as the vaccine has shown significant effectiveness in preventing infection from nine high-risk types of HPV among adolescents and young adults. According to the latest information, the eligibility for the 9-valent HPV vaccine has now been extended up to age 45, meaning women over 26 can also receive the 9-valent cervical cancer vaccine. This expansion aims to provide broader protection and reduce the incidence of cervical cancer and other related malignancies. However, please note that prior to vaccination, it is important to consult a doctor and undergo relevant examinations and assessments to ensure that your personal health condition is suitable for vaccination.